Treatment of AGL.
D000630:Aminopterin / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D004361:Drug Tolerance; D064420:Drug-Related Side Effects and Adverse Reactions; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007239:Infections / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D010357:Patient Isolators / Q000009:adverse effects; D013256:Steroids / Q000009:adverse effects; D065227:Transfusion Reaction
D013256:Steroids; D003561:Cytarabine; D000630:Aminopterin; D003348:Cortisone; D003630:Daunorubicin